Stockreport

Health Canada approval of new ALS drug allows Canadians to get access first [Toronto Globe and Mail (Ontario, Canada)]

Amylyx Pharmaceuticals, Inc.  (AMLX) 
PDF Health Canada has become the first regulator in the world to approve a new amyotrophic lateral sclerosis (ALS) drug, only the third therapy for treatment of the fatal mo [Read more]